| Similar Articles |
|---|
 |
Scientific American
October 2005
Boyce Rensberger |
Science Abuse In The Republican War on Science by Chris Mooney, the author posits that some of those in power may grasp how research works but nonetheless are willing to subvert science's knowledge and expert opinion for short-term political and economic gains.   |
Reason
May 2005
Ronald Bailey |
Aborting Plan B Barr Pharmaceuticals wants to offer its emergency contraceptive levonorgestrel, marketed as Plan B, over the counter rather than by prescription. The FDA delayed an anticipated decision on the issue indefinitely, adding another chapter to a long and heavily politicized debate. |
Wired
June 26, 2007
Josh McHugh |
Climate Change-Hurricane Debate Too Close to Call, Author Says The debate over the cause for an increase in hurricanes continues, but it may be too soon to take sides. |
Reason
December 2004
Julian Sanchez |
Soundbite An interview with Joe Trippi who pioneered the political use of blogs and other online tools. His new campaign memoir, The Revolution Will Not Be Televised reminds us that it doesn't mean the rhetoric isn't true. |
Reason
September 2004
Julian Sanchez |
Soundbite An interview with co-author Adrian Wooldridge on the new, and surprisingly neutral look at the American right presented in The Right Nation. |
InternetNews
March 7, 2011 |
House Dems Complain of Net Neutrality Process Minority subcommittee leadership appeals to their Republican counterparts to slow down the move to overturn the FCC's net neutrality order, seeks amendment debate. |
Popular Mechanics
September 2, 2008
Matt Sullivan |
Adam Savage's Plan to Banish Boring Science Education & More Adam Savage discusses everything from No Child Left Behind to the evolution debate in America's schools |
Pharmaceutical Executive
October 1, 2006
George Koroneos |
Pharm Exec Q&A: Inside View The Union of Concerned Scientists made revelations about the FDA's own scientific culture. Here, Francesca Grifo, director of scientific integrity program at UCS, talks about the findings. |
The Motley Fool
February 2, 2005
Rich Duprey |
Aastrom to Leap Into Trials The biotech firm advances to the next stage of clinical studies in stem cell research. Investors, take note. |
The Motley Fool
April 14, 2008
Brian Orelli |
Stem Cells Show Off The FDA moves closer to setting up stem cell clinical trials, setting guidelines that put treatment safety first and foremost. |
Geotimes
September 2005
Nisbet & Nisbet |
Evolution & Intelligent Design: Understanding Public Opinion Tensions in American society over religious and scientific accounts of human origins are centuries old, and the divide between the two contending worldviews continues today as part of an escalating political conflict over science education. |
Chemistry World
September 2006
Mark Peplow |
Editorial: Making a Monkey Out of Evolution If a scientific concept as well supported as evolution can be widely regarded as false, what hope for the greenhouse effect, radiocarbon dating, or the second law of thermodynamics? Chemists have as much responsibility as other scientists to uphold the value of hard evidence. |
Geotimes
October 2005
Megan Sever |
Evolution Battles Continue The battle over the teaching of evolution in public schools in the United States reached a fervor this week, as a number of prominent scientists testified in an ongoing court trial that pits evolution against intelligent design. |
T.H.E. Journal
August 2007
Christina C. Schaller |
Let Academic Freedom Ring Unless we liberate science from political and religious forces, our students don't stand a chance in the global workforce. |
The Motley Fool
November 28, 2007
Brian Orelli |
Stem Your Expectations of Stem-Cell Discoveries Making "stem" cells out of skin cells isn't all it's cracked up to be. The recent discovery has a long way to go before it can catch up to the research currently being done with stem cells. |
BusinessWeek
August 2, 2004 |
A VC's Political Seed Money Silicon Valley's Andy Rappaport explains why he's pouring cash and time into defeating Bush and shaping the Democratic Party's direction |
Pharmaceutical Executive
September 1, 2005
Humphrey Taylor |
Back Page: Evolution? It's Not Right! The Religious Right is likely to influence the future of medicine, healthcare, and medical research. |
Reason
February 2004
Tim Cavanaugh |
Political Body Snatchers How can you tell the evil party from the stupid party? |
BusinessWeek
May 24, 2004 |
Michael J. Fox's Take on Stem Cells Opposition to this research is "ridiculous," says the actor. It will happen "in other countries now, and we won't have as much input" |
Salon.com
August 7, 2000
David Horowitz |
Why Bush will win With a unified base, Bush is moving to the center, while Gore continues to alienate his base with the selection of Sen. Joe Lieberman as his running mate. |
The Motley Fool
December 5, 2007
Brian Lawler |
The FDA Says It Needs a Pep Pill Drugmakers offering new treatments might be discouraged by the FDA's latest report, in which the agency makes its case for additional funding from Congress. |
Salon.com
August 28, 2000
David Horowitz |
Persuading people you care Republicans need to take a lesson from Bill Clinton and wrap themselves in the flag of the "dispossessed." |
Pharmaceutical Executive
April 1, 2007
McCook & Daniels |
Making the Switch More companies are using Rx-to-OTC switches to extend a brand's life cycle. Prilosec did it. Here, experts dish on how you can do it too. |
BusinessWeek
September 22, 2003
Faith Arner |
Boston Scientific's "Professional Worrier" CEO Jim Tobin's cleanup "took longer than I thought," but now he's on the verge of a major upswing |
BusinessWeek
July 26, 2004
Arlene Weintraub |
The Stem-Cell Flap: Simmer Down Advocates are overstating stem cells' near-term ability to treat grave illnesses. In doing so, they not only distort the science; the hopes they raise among many people who are sick today are also sure to be dashed. |
BusinessWeek
September 30, 2010
Jonathan D. Salant |
State Candidates Catch A Wave of GOP Cash Companies are spending big on state races in hopes of electing more Republican governors and state legislators. |
Pharmaceutical Executive
October 1, 2006
Jill Wechsler |
Washington Report: After Plan B: Out of the Quagmire, into the Data The morning-after pill goes OTC, with some special requirements. But is FDA's drug information system up to the task of tracking how it is used? |
BusinessWeek
July 18, 2005 |
Research and "False Expectations" While Korean scientist Hwang Woo Suk is eager to see practical applications of his work, he warns that optimism needs to be qualified by reality. |
Wired
October 23, 2007
Clive Thompson |
Clive Thompson on Why Science Will Triumph Only When Theory Becomes Law Turns out, the real culture war in science isn't about science at all -- it's about language. And to fight this war, we need to change the way we talk about scientific knowledge. |
Salon.com
July 10, 2000
Leah Kohlenberg |
The silence of the Pill The FDA may make oral contraceptives available over the counter -- and neither pro-life nor pro-choice groups seem to care. |
BusinessWeek
April 25, 2005
Catherine Arnst |
When Patients Say: Don't Ban My Drug Emotional lobbying can keep a treatment on the market despite serious side effects. |
Reason
February 2003
John J. Pitney Jr. |
Gone With the Vote For the GOP in the South, Reconstruction isn't quite over. A half-century ago, Southern Democrats campaigned by opposing color-blind laws, stirring up racial fears, and silencing those who opposed them. They still do. |
Pharmaceutical Executive
December 1, 2010
Jill Wechsler |
New Ballgame in Washington Republican gains in Congress create uncertainty for health reform, drug regulation, and biomedical research |
Pharmaceutical Executive
April 1, 2006
Jill Wechsler |
Washington Report: A Warning Trend Washington's new answer to drug safety concerns is more warnings and more disclosure of undigested data. But warnings can go too far. Haven't FDA's critics ever heard the story of the boy who cried wolf? |
